Shandong Weigao Group Medical Polymer Company Limited

SEHK:1066 Stock Report

Market Cap: HK$22.3b

Shandong Weigao Group Medical Polymer Past Earnings Performance

Past criteria checks 2/6

Shandong Weigao Group Medical Polymer has been growing earnings at an average annual rate of 8.4%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 8.6% per year. Shandong Weigao Group Medical Polymer's return on equity is 8.6%, and it has net margins of 15.1%.

Key information

8.4%

Earnings growth rate

8.2%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate8.6%
Return on equity8.6%
Net Margin15.1%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Mar 17
Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Jan 28
Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Jan 13
Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 17
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Dec 05
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Oct 18
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Oct 06
Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Sep 10
Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Aug 29
Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Jul 09
Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Jun 26
Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)

Jun 02
Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)

These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well

Apr 24
These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 49% Below Their Intrinsic Value Estimate

Mar 31
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 49% Below Their Intrinsic Value Estimate

Here's What Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shareholder Ownership Structure Looks Like

Mar 11
Here's What Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shareholder Ownership Structure Looks Like

The Trends At Shandong Weigao Group Medical Polymer (HKG:1066) That You Should Know About

Feb 26
The Trends At Shandong Weigao Group Medical Polymer (HKG:1066) That You Should Know About

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Is Well Worth Watching

Feb 13
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Is Well Worth Watching

Revenue & Expenses Breakdown
Beta

How Shandong Weigao Group Medical Polymer makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:1066 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2313,2292,0023,838593
30 Sep 2313,2822,1693,694590
30 Jun 2313,4382,3993,631592
31 Mar 2313,5292,5613,604569
31 Dec 2213,6192,7233,577547
30 Sep 2213,8902,6883,707549
30 Jun 2214,0582,5893,755546
31 Mar 2213,6332,4323,793525
31 Dec 2113,2092,2763,830503
30 Sep 2112,9232,2883,865493
30 Jun 2112,6362,3003,900484
31 Mar 2112,1292,1943,775454
31 Dec 2011,6222,0873,651424
30 Sep 2011,1391,9983,636403
30 Jun 2010,6561,9093,622382
31 Mar 2010,5201,8793,699394
31 Dec 1910,3841,8503,776406
30 Sep 199,9931,8053,696374
30 Jun 199,6021,7603,615341
31 Mar 199,2051,6163,500326
31 Dec 188,8091,4733,385311
30 Jun 187,4651,2552,842280
31 Mar 186,8791,2552,593277
31 Dec 176,2931,2552,344274
30 Jun 175,4021,2971,918258
31 Mar 175,5111,1652,062262
31 Dec 165,6201,0332,206266
30 Sep 166,4841,0102,469302
30 Jun 166,2379142,367302
31 Mar 166,0781,0132,153297
31 Dec 155,9191,1131,938293
30 Sep 155,8781,2371,920290
30 Jun 155,6101,1961,839262
31 Mar 155,5481,1611,828252
31 Dec 145,2781,0851,742238
30 Sep 145,0113071,646222
30 Jun 144,9964311,583222
31 Mar 144,7693761,521215
31 Dec 134,6133881,453209
30 Sep 134,2301,0071,212319
30 Jun 133,9729311,176268
31 Mar 133,8401,0111,131218

Quality Earnings: 1066 has high quality earnings.

Growing Profit Margin: 1066's current net profit margins (15.1%) are lower than last year (20%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1066's earnings have grown by 8.4% per year over the past 5 years.

Accelerating Growth: 1066's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1066 had negative earnings growth (-26.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (9.2%).


Return on Equity

High ROE: 1066's Return on Equity (8.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.